Diabetes Is A Global Tsunami.  MIMOSA Is Part Of The Solution


Beyond Human Vision

The MIMOSA (MultIspectral MObile tiSsue Assessment device) can photograph wounds with near-infrared light, just beyond the range of human vision. Taking these photographs using different “colors” of light, we can see key molecules that indicate tissue health.  Using this non-invasive technology, we can predict when an ulcer might be forming before it is visible to the naked eye.


Anytime anywhere

Up until now, this technology has been big and bulky and only available in hospitals. MIMOSA is major advance because of its size: we have miniaturized and adapted the technology to work with a cell phone, which can be used by a patient anytime, anywhere.  The images MIMOSA takes can then be sent securely to a clinic where a healthcare provider can review them.

Remote Monitoring

Monitoring patients at home saves hundreds of thousands of hospital and home care visits, while still ensuring that patients are monitored regularly. Remote monitoring with MIMOSA is also useful in underserviced communities that do not have access to specialized healthcare.


The MIMOSA: Seeing what We Cannot

Personal glucometers revolutionized diabetes management 35 years ago; a personal diagnostic device for “foot health” monitoring could have the same impact on DFU-related amputation through early recognition and intervention. PREVENTION IS THE KEY.


Diabetes is the leading cause of non-traumatic lower limb amputation

Most people think diabetes is a mild disease that can be controlled by watching sugar intake or with medication. While this can be true, if diabetes is left untreated or isn’t properly managed it can lead to serious health complications like heart disease and nerve damage. Because of these complications, diabetics often lose feeling in their feet, and can develop deep open wounds (called “ulcers”) from a sock that rubs them the wrong way or a shoe that does not fit properly. They simply cannot tell that they have a problem until it is too late. 

-Learn More


23 times more likely to have a lower limb amputation

The words “foot ulcer” puts fear into a diabetic patient’s heart. Ulcers are treatable if caught early. People with diabetes are 23 times more likely to have a lower limb amputation than the general population because there are no early detection tools.  A more frightening statistic is that 30% of diabetics who have an ulcer-related amputation die within 1 year - more than your life time risk of dying of cancer. 15% to 25% of people with diabetes will have a foot ulcer at some point in their lives.

Affecting Every-day Canadians

Canada has one of the highest rates of diabetes in the world, with more than three million people with the disease, a number which has doubled since 2000 and continues to grow. Worldwide, more than 20 people are diagnosed with this disease every hour of the day.  Most people living with diabetes are middle aged and are still working.  Having a foot ulcer affects their ability to work, provide for their families and enjoy their lives. 


Costing Canadian's $547 Million Dollars a Year

Beyond the personal cost to an individual who cannot work, treating diabetic foot ulcers costs the Canadian health care system $547 Million dollars a year. The cost of an amputation to the Canadian health care system is 10 to 40 times greater than the cost of effective prevention. 

How to get Involved!

The MIMOSA Founders

Karen 3 (headshot).jpg

Karen Cross, MD, PhD, FRCSC

Dr. Karen Cross is a Plastic, Reconstructive and Aesthetic Surgeon and a Surgeon Scientist at St. Michael’s Hospital. She is an assistant professor at the University of Toronto and an adjunctive professor at Ryerson University. 


General Leung, PhD, MSc

Dr. Leung is the Magnetic Resonance physicist at St. Michael’s Hospital MR Research Centre and assistant professor at the University of Toronto in the Department of Medical imaging.




 Keith Wong  Senior Software Architect

Keith Wong

Senior Software Architect

 Chris Stewart  Software Developer

Chris Stewart

Software Developer

 Dragos Duta  Regulatory Lead

Dragos Duta

Regulatory Lead

 Ruben Pinto  Data Processing Specialist

Ruben Pinto

Data Processing Specialist

 Paul Hunter  Project Coordinator

Paul Hunter

Project Coordinator

IMG_1167 copy.jpg

Want To Hear From Us? 

Name *

MIMOSA In The News


CBC Radio Interview 

On September 6th, 2016 Dr. Karen Cross (Co-Founder and CEO, Mimosa Diagnostics) was interviewed live on CBC Newfoundland and Labrador morning radio show, The St. John's Morning Show.


St. Michael's Hospital Magazine 

MIMOSA was featured in the St. Michael's Hospital magazine in October 2016.


Canadian Healthcare Technology

MIMOSA was featured in Canadian Healthcare Technology in March 2017. This is an online and print news magazine covering the 'new and noteworthy in healthcare technology.'


St. Michael's Hospital Magazine

MIMOSA was featured in the St. Michael's Hospital magazine in March 2017.